Financial Ratios ACM Research (Shanghai), Inc.
Stocks
688082
CNE100004ZD8
Semiconductor Equipment & Testing
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 284.00 CNY | +7.17% |
|
+12.28% | +61.32% |
| 28/04 | ACM Research Shanghai's Q1 Profit Plunges 58%; Shares Down 11% | MT |
| 27/04 | ACM Research Shanghai Q1 net profit down 57.7% Y/Y | RE |
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
Return on Assets | 2.7 | 5.33 | 5.73 | 6.84 | 5 | ||||
Return on Total Capital | 3.44 | 6.95 | 7.83 | 9.38 | 6.39 | ||||
Return On Equity % | 9.08 | 12.93 | 15.2 | 16.33 | 13.2 | ||||
Return on Common Equity | 9.08 | 12.93 | 15.2 | 16.33 | 13.21 | ||||
Margin Analysis | |||||||||
Gross Profit Margin % | 42.52 | 48.32 | 51.86 | 48.46 | 46.73 | ||||
SG&A Margin | 13.79 | 12.78 | 13.57 | 12.85 | 11.91 | ||||
EBITDA Margin % | 11.43 | 22.23 | 22.22 | 22.2 | 19.57 | ||||
EBITA Margin % | 10.98 | 21.62 | 21.29 | 21.35 | 18.31 | ||||
EBIT Margin % | 10.89 | 21.56 | 21.15 | 21.32 | 18.28 | ||||
Income From Continuing Operations Margin % | 16.43 | 23.27 | 23.42 | 20.53 | 20.56 | ||||
Net Income Margin % | 16.43 | 23.27 | 23.42 | 20.53 | 20.57 | ||||
Net Avail. For Common Margin % | 16.43 | 23.27 | 23.42 | 20.53 | 20.57 | ||||
Normalized Net Income Margin | 7.21 | 15.77 | 15.11 | 13.98 | 11.51 | ||||
Levered Free Cash Flow Margin | -24.84 | -62.28 | -9.86 | 4.1 | -11.42 | ||||
Unlevered Free Cash Flow Margin | -24.61 | -62.02 | -9.54 | 4.4 | -11.04 | ||||
Asset Turnover | |||||||||
Asset Turnover | 0.4 | 0.4 | 0.43 | 0.51 | 0.44 | ||||
Fixed Assets Turnover | 22.58 | 8.59 | 3.88 | 3.48 | 3.64 | ||||
Receivables Turnover (Average Receivables) | 3.88 | 3.37 | 2.75 | 2.85 | 2.38 | ||||
Inventory Turnover (Average Inventory) | 0.91 | 0.72 | 0.57 | 0.71 | 0.8 | ||||
Short Term Liquidity | |||||||||
Current Ratio | 4.59 | 2.63 | 2.64 | 2.69 | 3.75 | ||||
Quick Ratio | 3.31 | 1.19 | 1.2 | 1.43 | 2.57 | ||||
Operating Cash Flow to Current Liabilities | -0.15 | -0.11 | -0.15 | 0.34 | 0.06 | ||||
Days Sales Outstanding (Average Receivables) | 94.16 | 108.27 | 132.8 | 128.23 | 153.34 | ||||
Days Outstanding Inventory (Average Inventory) | 403.13 | 508.01 | 645 | 515.58 | 457.07 | ||||
Average Days Payable Outstanding | 106.31 | 113.25 | 144.05 | 170.26 | 161.67 | ||||
Cash Conversion Cycle (Average Days) | 390.98 | 503.03 | 633.75 | 473.55 | 448.74 | ||||
Long Term Solvency | |||||||||
Total Debt/Equity | 5.2 | 10.03 | 9.2 | 16.31 | 14.01 | ||||
Total Debt / Total Capital | 4.94 | 9.12 | 8.43 | 14.03 | 12.29 | ||||
LT Debt/Equity | 3.3 | 2.5 | 4.73 | 10.17 | 8.08 | ||||
Long-Term Debt / Total Capital | 3.14 | 2.27 | 4.33 | 8.75 | 7.09 | ||||
Total Liabilities / Total Assets | 24.02 | 32.43 | 33.79 | 36.8 | 28.71 | ||||
EBIT / Interest Expense | 28.91 | 51.58 | 40.97 | 44.54 | 30.05 | ||||
EBITDA / Interest Expense | 32.73 | 54.63 | 44.15 | 47.21 | 32.87 | ||||
(EBITDA - Capex) / Interest Expense | 22.96 | -2.47 | 24.3 | 25.87 | 20.66 | ||||
Total Debt / EBITDA | 1.25 | 0.84 | 0.67 | 0.99 | 1.39 | ||||
Net Debt / EBITDA | -16.72 | -1.75 | -1.21 | -1.24 | -4.16 | ||||
Total Debt / (EBITDA - Capex) | 1.79 | -18.67 | 1.22 | 1.8 | 2.21 | ||||
Net Debt / (EBITDA - Capex) | -23.84 | 38.71 | -2.19 | -2.26 | -6.62 | ||||
Growth Over Prior Year | |||||||||
Total Revenues, 1 Yr. Growth % | 60.88 | 77.25 | 35.34 | 44.48 | 20.8 | ||||
Gross Profit, 1 Yr. Growth % | 57.51 | 101.45 | 45.27 | 38.45 | 16.48 | ||||
EBITDA, 1 Yr. Growth % | 27.08 | 142.31 | 34.71 | 43.27 | 4.98 | ||||
EBITA, 1 Yr. Growth % | 24.72 | 142.34 | 32.72 | 43.78 | 2.07 | ||||
EBIT, 1 Yr. Growth % | 25.06 | 144.35 | 32.81 | 45.61 | 3.59 | ||||
Earnings From Cont. Operations, 1 Yr. Growth % | 35.31 | 151.08 | 36.21 | 26.65 | 21.01 | ||||
Net Income, 1 Yr. Growth % | 35.31 | 151.08 | 36.21 | 26.65 | 21.05 | ||||
Normalized Net Income, 1 Yr. Growth % | 69.56 | 173.91 | 29.66 | 33.66 | -0.56 | ||||
Diluted EPS Before Extra, 1 Yr. Growth % | 34 | 128.36 | 33.99 | 27.32 | 17.62 | ||||
Accounts Receivable, 1 Yr. Growth % | 111.73 | 101.58 | 47.31 | 36.77 | 48.16 | ||||
Inventory, 1 Yr. Growth % | 134.74 | 86.36 | 45.93 | 7.82 | 13.93 | ||||
Net Property, Plant and Equip., 1 Yr. Growth % | 137.85 | 462.15 | 152.58 | 25.07 | 7.67 | ||||
Total Assets, 1 Yr. Growth % | 243.77 | 29 | 19.3 | 24.35 | 55.79 | ||||
Tangible Book Value, 1 Yr. Growth % | 383.67 | 14.47 | 17.1 | 18.93 | 76.07 | ||||
Common Equity, 1 Yr. Growth % | 359.15 | 14.73 | 16.91 | 18.69 | 75.71 | ||||
Cash From Operations, 1 Yr. Growth % | 114.38 | 42.04 | 58.89 | -384.84 | -80.36 | ||||
Capital Expenditures, 1 Yr. Growth % | -83.23 | 1.05T | -41.88 | 44.02 | -12.18 | ||||
Levered Free Cash Flow, 1 Yr. Growth % | -23.05 | 401.37 | -78.57 | -163.63 | -436.46 | ||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -23.2 | 404.66 | -79.18 | -170.72 | -403.15 | ||||
Dividend Per Share, 1 Yr. Growth % | - | - | 68.55 | 4.78 | -5.13 | ||||
Compound Annual Growth Rate Over Two Years | |||||||||
Total Revenues, 2 Yr. CAGR % | 46.35 | 68.87 | 54.88 | 39.83 | 32.11 | ||||
Gross Profit, 2 Yr. CAGR % | 42.2 | 78.13 | 71.07 | 40.04 | 26.99 | ||||
EBITDA, 2 Yr. CAGR % | 21.1 | 109.34 | 81.03 | 39.45 | 23.52 | ||||
EBITA, 2 Yr. CAGR % | 19.91 | 108.65 | 79.71 | 38.69 | 22.04 | ||||
EBIT, 2 Yr. CAGR % | 19.48 | 109.51 | 80.15 | 39.06 | 22.82 | ||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 40.49 | 84.32 | 84.93 | 31.34 | 23.8 | ||||
Net Income, 2 Yr. CAGR % | 40.49 | 84.32 | 84.93 | 31.34 | 23.82 | ||||
Normalized Net Income, 2 Yr. CAGR % | 20.69 | 156.4 | 88.45 | 31.64 | 15.29 | ||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 36.42 | 74.93 | 74.92 | 30.61 | 22.37 | ||||
Accounts Receivable, 2 Yr. CAGR % | 60.72 | 106.59 | 72.32 | 41.94 | 42.35 | ||||
Inventory, 2 Yr. CAGR % | 116.73 | 109.15 | 64.91 | 25.44 | 10.83 | ||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 139.17 | 265.66 | 276.81 | 77.74 | 16.05 | ||||
Total Assets, 2 Yr. CAGR % | 120.12 | 110.59 | 24.06 | 21.8 | 39.18 | ||||
Tangible Book Value, 2 Yr. CAGR % | 139.59 | 135.29 | 15.78 | 18.01 | 44.71 | ||||
Common Equity, 2 Yr. CAGR % | 140.87 | 129.51 | 15.81 | 17.8 | 44.42 | ||||
Cash From Operations, 2 Yr. CAGR % | 61.31 | 74.5 | 50.23 | 112.74 | -25.21 | ||||
Capital Expenditures, 2 Yr. CAGR % | 142.13 | 38.88 | 158.56 | -8.51 | 12.47 | ||||
Levered Free Cash Flow, 2 Yr. CAGR % | 138.51 | 84.9 | 3.66 | -64.12 | 46.31 | ||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 145.6 | 85.21 | 2.5 | -62.75 | 46.42 | ||||
Dividend Per Share, 2 Yr. CAGR % | - | - | - | 32.9 | -0.3 | ||||
Compound Annual Growth Rate Over Three Years | |||||||||
Total Revenues, 3 Yr. CAGR % | 43.35 | 56 | 56.86 | 51.33 | 33.18 | ||||
Gross Profit, 3 Yr. CAGR % | 41.45 | 59.71 | 66.42 | 58.08 | 31.7 | ||||
EBITDA, 3 Yr. CAGR % | 30.83 | 71.65 | 80.97 | 67.87 | 27.46 | ||||
EBITA, 3 Yr. CAGR % | 30.16 | 71.22 | 79.69 | 67.27 | 25.83 | ||||
EBIT, 3 Yr. CAGR % | 29.89 | 71.12 | 79.97 | 67.81 | 26.06 | ||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 42.23 | 70.49 | 66.64 | 63.01 | 27.8 | ||||
Net Income, 3 Yr. CAGR % | 42.23 | 70.49 | 66.64 | 63.01 | 27.82 | ||||
Normalized Net Income, 3 Yr. CAGR % | 31.09 | 78.08 | 104.27 | 68.06 | 19.89 | ||||
Diluted EPS Before Extra, 3 Yr. CAGR % | - | 61.98 | 60.05 | 57.35 | 26.13 | ||||
Accounts Receivable, 3 Yr. CAGR % | 46.17 | 73.33 | 84.57 | 59.55 | 43.99 | ||||
Inventory, 3 Yr. CAGR % | 76.13 | 106.09 | 85.51 | 43.13 | 21.48 | ||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 83.39 | 218 | 223.23 | 160.9 | 50.39 | ||||
Total Assets, 3 Yr. CAGR % | 115.19 | 84.21 | 74.25 | 24.16 | 32.21 | ||||
Tangible Book Value, 3 Yr. CAGR % | 221.34 | 87.3 | 86.46 | 16.82 | 34.85 | ||||
Common Equity, 3 Yr. CAGR % | 221.39 | 88.11 | 83.3 | 16.77 | 34.6 | ||||
Cash From Operations, 3 Yr. CAGR % | 69.56 | 54.61 | 69.14 | 85.94 | -3.85 | ||||
Capital Expenditures, 3 Yr. CAGR % | 59.34 | 307.04 | 3.88 | 112.74 | -9.75 | ||||
Levered Free Cash Flow, 3 Yr. CAGR % | 230.92 | 193.48 | -9.85 | -13.57 | -24.33 | ||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 203.51 | 199.79 | -10.61 | -11.2 | -25.08 | ||||
Dividend Per Share, 3 Yr. CAGR % | - | - | - | - | 18.77 | ||||
Compound Annual Growth Rate Over Five Years | |||||||||
Total Revenues, 5 Yr. CAGR % | - | 62.5 | 47.86 | 49.32 | 46.45 | ||||
Gross Profit, 5 Yr. CAGR % | - | 65.17 | 52.63 | 51.53 | 48.61 | ||||
EBITDA, 5 Yr. CAGR % | - | 205.28 | 59.87 | 58.09 | 55.56 | ||||
EBITA, 5 Yr. CAGR % | - | 259.5 | 59.3 | 57.51 | 54.17 | ||||
EBIT, 5 Yr. CAGR % | - | 350.33 | 59.17 | 57.49 | 54.46 | ||||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | 127.95 | 57.98 | 53.6 | 47.96 | ||||
Net Income, 5 Yr. CAGR % | - | 127.95 | 57.98 | 53.6 | 47.97 | ||||
Normalized Net Income, 5 Yr. CAGR % | - | 222.66 | 62.48 | 57.81 | 62.49 | ||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | - | 48.62 | 43.76 | ||||
Accounts Receivable, 5 Yr. CAGR % | - | 62.08 | 56.12 | 60.02 | 66.36 | ||||
Inventory, 5 Yr. CAGR % | - | 81.78 | 71.55 | 68.97 | 50.97 | ||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | 109.22 | 144.61 | 151.98 | 114.57 | ||||
Total Assets, 5 Yr. CAGR % | - | 91.08 | 72.64 | 56.11 | 59.27 | ||||
Tangible Book Value, 5 Yr. CAGR % | - | 157.89 | 113.61 | 55.7 | 68.48 | ||||
Common Equity, 5 Yr. CAGR % | - | 157.96 | 113.66 | 55.99 | 66.63 | ||||
Cash From Operations, 5 Yr. CAGR % | - | 97.28 | 61.54 | 75.66 | 22.04 | ||||
Capital Expenditures, 5 Yr. CAGR % | - | 219.71 | 93.39 | 124.04 | 7.23 | ||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | 103.04 | 26.62 | 8.17 | ||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | 91.86 | 30.18 | 7.61 |
- Stock Market
- Stocks
- 688082 Stock
- Financials ACM Research (Shanghai), Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















